Eiger BioPharmaceuticals, Inc.(EIGR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EIGR Eiger BioPharmaceuticals, Inc.

退市 11-25 16:32:56 EST

1.73

+0.00

0.00%

最高1.73	最低1.73	成交量0.00
今开1.73	昨收1.73	日振幅0.00%
总市值255.44万	流通市值219.60万	总股本148.08万
成交额0.00	换手率0.00%	流通股本127.30万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EIGR","market":"US","secType":"STK","nameCN":"Eiger BioPharmaceuticals, Inc.","latestPrice":1.725,"timestamp":1732568400000,"preClose":1.725,"halted":4,"volume":0,"delay":0,"floatShares":1273039,"shares":1480797,"eps":-50.77944,"marketStatus":"退市","marketStatusCode":4,"change":0,"latestTime":"11-25 16:32:56 EST","open":1.725,"high":1.725,"low":1.725,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-50.77944,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732582800000},"adr":0,"adjPreClose":1.725,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/EIGR","defaultTab":"news","newsList":[{"id":"2426314410","title":"艾格生物制药公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2426314410","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426314410?lang=zh_cn&edition=full","pubTime":"2024-04-10 02:44","pubTimestamp":1712688292,"startTime":"0","endTime":"0","summary":"   * 艾格生物制药公司公布的截至12月底的季度调整后每股亏损49.39美元，低于去年同期的每股收益17.10美元。分析师对该季度的唯一预测是每股亏损 7.50 美元。* 收入同比增长 41.1%，达到 380 万美元；分析师预期为 648 万美元。* 艾格生物制药公司公布的本季度每股收益为亏损49.39美元。* 该公司一季度亏损 1345 万美元。* Eiger BioPharmaceuticals Inc 的股价本季度下跌了 57.8%，今年迄今为止下跌了 68.7%。华尔街对艾格生物制药公司 12 个月目标价的中位数为 30.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIGR","BK4139"],"gpt_icon":0},{"id":"2426160241","title":"Eiger Biopharmaceuticals, Inc.盘中异动 快速下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426160241","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426160241?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:07","pubTimestamp":1712675262,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日23时07分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价快速跳水5.21%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409230743861e4432&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409230743861e4432&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHI","BK4585","EIGR","HDV","BK4139","BK4588","PBH","BK4007","BK4123","PL"],"gpt_icon":0},{"id":"2425977709","title":"Eiger Biopharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425977709","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425977709?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:32","pubTimestamp":1712583132,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时32分，Eiger Biopharmaceuticals, Inc.股票出现波动，股价快速下挫5.19%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082132127a516637&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082132127a516637&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HDV","CHI","BK4139","PL","LGVN","BK4585","BK4588","PBH","BK4123","EIGR","BK4007"],"gpt_icon":0},{"id":"2425631065","title":"Eiger Biopharmaceuticals, Inc.盘中异动 早盘大幅拉升7.81%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425631065","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425631065?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:31","pubTimestamp":1712323912,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时31分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价大幅拉升7.81%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052131528af4350b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052131528af4350b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBH","BK4139","BK4007","PL","BK4585","HDV","CHI","BK4588","EIGR","BK4123"],"gpt_icon":0},{"id":"2424239269","title":"Eiger Biopharmaceuticals, Inc.股价飙升13.33% 市值涨36.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424239269","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424239269?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:31","pubTimestamp":1712237511,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时31分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价大幅拉升13.33%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042131518af10217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042131518af10217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PL","BK4123","BK4007","CHI","BK4585","PBH","BK4588","EIGR","HDV"],"gpt_icon":0},{"id":"2424874204","title":"艾格生物制药公司  预计每股亏损7.50美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2424874204","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424874204?lang=zh_cn&edition=full","pubTime":"2024-04-04 04:02","pubTimestamp":1712174565,"startTime":"0","endTime":"0","summary":"   * 艾格生物制药公司将于4月5日公布截至2023年12月31日的业绩报告，预计()，季度收入将有所增长。* 根据LSEG的数据，一位分析师预计，这家总部位于加利福尼亚州帕洛阿尔托的公司的营收将从去年同期的270万美元增长140.3%，达到647.9万美元。* LSEG分析师对艾格生物制药公司的平均预期是每股亏损7.50美元。* 华尔街对 Eiger BioPharmaceuticals Inc 的 12 个月目标价中值为 30.00 美元，高于其上一次收盘价 1.30 美元。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIGR"],"gpt_icon":0},{"id":"2424840483","title":"Eiger Biopharmaceuticals, Inc.盘中异动 早盘快速拉升6.15%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424840483","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424840483?lang=zh_cn&edition=full","pubTime":"2024-04-03 23:04","pubTimestamp":1712156677,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日23时04分，Eiger Biopharmaceuticals, Inc.股票出现波动，股价快速拉升6.15%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032304377a50fb33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032304377a50fb33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HDV","CHI","BK4139","PL","BK4585","BK4588","PBH","BK4123","EIGR","BK4007"],"gpt_icon":0},{"id":"2424474045","title":"Eiger Biopharmaceuticals, Inc.股价重挫12.23% 市值跌22.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424474045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424474045?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:35","pubTimestamp":1712064902,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时35分，Eiger Biopharmaceuticals, Inc.股票出现波动，股价快速下跌12.23%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022135028ae8bb1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022135028ae8bb1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBH","PL","CHI","BK4007","BK4585","BK4139","HDV","EIGR","BK4123","BK4588"],"gpt_icon":0},{"id":"2424721063","title":"Eiger BioPharmaceuticals Inc.（EIGR）一度下跌78%，这家罕见代谢疾病疗法研究公司申请破产。","url":"https://stock-news.laohu8.com/highlight/detail?id=2424721063","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424721063?lang=zh_cn&edition=full","pubTime":"2024-04-02 02:12","pubTimestamp":1711995127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","EIGR"],"gpt_icon":0},{"id":"2424742576","title":"BUZZ-艾格生物制药公司因申请破产保护而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2424742576","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424742576?lang=zh_cn&edition=full","pubTime":"2024-04-01 23:44","pubTimestamp":1711986283,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月1日 - ** 艾格生物制药公司  股价暴跌56.3%至2.15美元 ** 制药商称 (link) 已自愿申请破产保护** 还宣布以 \"跟踪马 \"的方式将其遗传性疾病药物 Zokinvy 出售给私人控股的 Sentynl Therapeutics，价格高达 2,600 万美元，但须经法院批准。 ** 跟踪马竞标是对破产公司资产的首次竞标** 打算在破产案期间出售其大部分资产，并促进其业务的有序收尾--EIGR ** 称患者将继续不间断地使用佐金维产品** 截至上一交易日收盘，股价累计下跌 68.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIGR","BK4139","BUZZ"],"gpt_icon":0},{"id":"2424274658","title":"媒体-艾格生物制药公司申请破产保护 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2424274658","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424274658?lang=zh_cn&edition=full","pubTime":"2024-04-01 22:40","pubTimestamp":1711982453,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月1日 - -- 来源链接：  -- 注：路透社未核实此报道，不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIGR","BK4139"],"gpt_icon":0},{"id":"2423105154","title":"艾格生物制药公司  预计每股亏损7.50美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2423105154","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2423105154?lang=zh_cn&edition=full","pubTime":"2024-03-30 04:28","pubTimestamp":1711744101,"startTime":"0","endTime":"0","summary":"   * 艾格生物制药公司   预计将在4月1日公布截至2023年12月31日的业绩报告。* 根据LSEG的数据，一位分析师预计，这家总部位于加利福尼亚州帕洛阿尔托的公司的营收将从去年同期的270万美元增长140.3%，达到647.9万美元。* LSEG 分析师对艾格生物制药公司的平均预期是每股亏损 7.50 美元。* 华尔街对艾格生物制药公司12个月目标价的中位数为90.00美元，高于其上次收盘价5.01美元。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIGR"],"gpt_icon":0},{"id":"2422791837","title":"Eiger Biopharmaceuticals, Inc.盘中异动 大幅下跌9.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422791837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422791837?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:47","pubTimestamp":1711547258,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时47分，Eiger Biopharmaceuticals, Inc.股票出现波动，股价急速下挫9.60%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272147387a4f8819&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272147387a4f8819&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4007","CHI","PBH","EIGR","HDV","BK4139","BK4123","PL"],"gpt_icon":0},{"id":"2422866649","title":"Eiger Biopharmaceuticals, Inc.股价重挫10.08% 市值跌33.96万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422866649","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422866649?lang=zh_cn&edition=full","pubTime":"2024-03-27 00:07","pubTimestamp":1711469221,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日00时07分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价急速跳水10.08%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270007027a4f395b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270007027a4f395b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4588","PL","CHI","EIGR","HDV","PBH","BK4123","BK4585"],"gpt_icon":0},{"id":"2422454577","title":"Eiger Biopharmaceuticals, Inc.盘中异动 早盘急速上涨5.38%报6.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422454577","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422454577?lang=zh_cn&edition=full","pubTime":"2024-03-25 22:15","pubTimestamp":1711376114,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日22时15分，Eiger Biopharmaceuticals, Inc.股票出现波动，股价快速拉升5.38%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252215147a4eea2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252215147a4eea2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHI","BK4585","EIGR","HDV","BK4139","BK4588","PBH","BK4007","BK4123","PL"],"gpt_icon":0},{"id":"2421862827","title":"艾格生物制药公司  预计每股亏损7.50美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2421862827","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421862827?lang=zh_cn&edition=full","pubTime":"2024-03-23 04:26","pubTimestamp":1711139184,"startTime":"0","endTime":"0","summary":"   * 艾格生物制药公司将于3月25日公布截至2023年12月31日的业绩报告，预计()。* 根据LSEG的数据，一位分析师预计，这家总部位于加利福尼亚州帕洛阿尔托的公司的营收将从去年同期的270万美元增长140.3%，达到647.9万美元。* LSEG 分析师对艾格生物制药公司的平均预期是每股亏损 7.50 美元。* 华尔街对艾格生物制药公司12个月目标价的中位数为90.00美元，高于其上次收盘价5.96美元。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIGR"],"gpt_icon":0},{"id":"2421846046","title":"Eiger Biopharmaceuticals, Inc.盘中异动 快速下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421846046","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421846046?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:33","pubTimestamp":1711121586,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时33分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价急速跳水5.20%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322233307791c51a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322233307791c51a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBH","BK4588","HDV","BK4123","BK4007","BK4585","CHI","BK4139","EIGR","PL"],"gpt_icon":0},{"id":"2421045187","title":"Eiger Biopharmaceuticals, Inc.盘中异动 大幅上涨12.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421045187","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421045187?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:33","pubTimestamp":1711027985,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时33分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价急速拉升12.85%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121330587a2348d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121330587a2348d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EIGR","PL","BK4123","CHI","BK4139","PBH","BK4585","BK4007","BK4588","HDV"],"gpt_icon":0},{"id":"2420740642","title":"Eiger Biopharmaceuticals, Inc.盘中异动 早盘股价大涨6.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420740642","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420740642?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:32","pubTimestamp":1710941539,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时32分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价急速拉升6.65%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202132198b4ca1bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202132198b4ca1bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HDV","BK4585","BK4588","EIGR","BK4007","PL","CHI","BK4123","BK4139","PBH"],"gpt_icon":0},{"id":"2420271428","title":"Eiger Biopharmaceuticals, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420271428","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420271428?lang=zh_cn&edition=full","pubTime":"2024-03-19 23:27","pubTimestamp":1710862049,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日23时27分，Eiger Biopharmaceuticals, Inc.股票出现异动，股价大幅上涨5.20%。Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Eiger Biopharmaceuticals, Inc.公司简介：Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司，专注于严重的、罕见的和超罕见疾病的药物的开发和商业化，这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031923272987e7a1b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031923272987e7a1b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHI","PBH","BK4007","PL","BK4123","BK4585","BK4139","HDV","EIGR","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eigerbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.8334},{"period":"ytd","weight":-0.7439}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Eiger BioPharmaceuticals, Inc.于2016年3月22日由Celladon Corporation和BioPharmaceuticals, Inc.合并而成。BioPharmaceuticals, Inc.在美国加州注册，于2000年12月21日成立，并于2012年4月在特拉华州重新合并，该公司是一家商业阶段的生物制药公司，专注于开发针对德尔塔病毒（HDV）和其他严重疾病的创新疗法。在他们的投资组合中，他们所有的罕见病项目都被美国食品药品监督管理局指定为突破疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.015036},{"month":2,"riseRate":0.25,"avgChangeRate":-0.063245},{"month":3,"riseRate":0.5,"avgChangeRate":0.021226},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.114426},{"month":5,"riseRate":0.666667,"avgChangeRate":0.126012},{"month":6,"riseRate":0.25,"avgChangeRate":-0.079491},{"month":7,"riseRate":0.5,"avgChangeRate":0.035154},{"month":8,"riseRate":0.625,"avgChangeRate":0.0559},{"month":9,"riseRate":0.125,"avgChangeRate":-0.153589},{"month":10,"riseRate":0.5,"avgChangeRate":-0.054406},{"month":11,"riseRate":0.625,"avgChangeRate":0.043051},{"month":12,"riseRate":0.375,"avgChangeRate":-0.082025}],"exchange":"NASDAQ","name":"Eiger BioPharmaceuticals, Inc.","nameEN":"Eiger BioPharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eiger BioPharmaceuticals, Inc.(EIGR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eiger BioPharmaceuticals, Inc.(EIGR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eiger BioPharmaceuticals, Inc.,EIGR,Eiger BioPharmaceuticals, Inc.股票,Eiger BioPharmaceuticals, Inc.股票老虎,Eiger BioPharmaceuticals, Inc.股票老虎国际,Eiger BioPharmaceuticals, Inc.行情,Eiger BioPharmaceuticals, Inc.股票行情,Eiger BioPharmaceuticals, Inc.股价,Eiger BioPharmaceuticals, Inc.股市,Eiger BioPharmaceuticals, Inc.股票价格,Eiger BioPharmaceuticals, Inc.股票交易,Eiger BioPharmaceuticals, Inc.股票购买,Eiger BioPharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eiger BioPharmaceuticals, Inc.(EIGR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eiger BioPharmaceuticals, Inc.(EIGR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}